The acquisition strengthens Astrix’s position as a premier global provider of pharmaceutical technology services while expanding its European footprint.

RED BANK, PA, UNITED STATES, August 13, 2026 /EINPresswire.com/ — Astrix, the leading provider of pharmaceutical technology services, today announced the acquisition of MAIN5, a Germany-based consulting firm specializing in digital transformation, regulatory affairs, quality management, and operational excellence for life science organizations.
The acquisition brings together two organizations with complementary capabilities and a shared commitment to helping life sciences companies accelerate innovation, modernize operations, and navigate an increasingly complex regulatory landscape. MAIN5 has established a strong reputation across Europe for delivering strategic consulting and digital transformation services to leading life science companies, with extensive expertise in regulatory operations, quality, and business process excellence.

By combining MAIN5’s deep European consulting expertise with Astrix’s market-leading pharmaceutical technology services, clients will benefit from expanded advisory services in the European market and enhanced support for complex business and digital transformation initiatives.
“Our clients are looking for strategic partners that understand both the science and the technology required to bring life-changing therapies to market,” said Dale Curtis, Chief Executive Officer of Astrix. “MAIN5 has built an outstanding reputation for helping life sciences organizations plan for and then transform critical business processes while maintaining the highest regulatory standards. Together, we will deliver even greater value to our clients and the industry as a whole.”

Founded in Germany, MAIN5 has supported leading life science organizations through digital transformation initiatives, regulatory strategy, quality management, and operational excellence programs. The firm’s experienced consultants serve clients throughout Europe and beyond, helping organizations improve efficiency while meeting evolving regulatory requirements.
“Joining Astrix marks an exciting new chapter for MAIN5, our employees, and our clients,” said Tore Bergsteiner, Managing Partner of MAIN5. “From our first conversations, it was clear that our organizations share the same client-first philosophy and passion for solving complex challenges in the life sciences industry. Together, we can offer our clients a broader portfolio of services, deeper technical expertise, and truly global support while preserving the collaborative culture and specialized knowledge that have defined MAIN5.”
The acquisition further strengthens Astrix’s global presence and reinforces its long-term strategy of investing in specialized scientific expertise that helps life sciences organizations accelerate digital transformation, improve regulatory compliance, and optimize operations.
MAIN5 will continue serving clients under the Astrix organization, ensuring continuity for existing engagements while providing access to additional capabilities and global resources.

About Astrix
Astrix is the global leader in delivering innovative strategies and solutions to the life sciences industry. Powered by world-class people, proven processes, and advanced technology, Astrix partners with clients to drive measurable improvements in business performance, scientific advancement, and clinical outcomes—ultimately driving towards a goal of improving quality of life. Founded by scientists to address the industry’s most complex challenges, Astrix provides a growing portfolio of strategic and technical services that deliver immediate impact while enabling long-term digital transformation. Our deep expertise spans strategic planning, data strategy, AI/ML readiness and technologies, lab informatics, and modern clinical operations and eClinical platforms so we can successfully deliver solutions that have high impact and drive better outcomes for everyone.
To learn more about Astrix’s market-leading pharmaceutical technology services, visit www.astrixinc.com.

About MAIN5
MAIN5 GmbH & Co. KGaA is an independent and successful management consulting company headquartered in Frankfurt am Main, Germany. We solve key challenges of our customers sustainably and reliably, each of which is of high relevance in the growing international competition. Our focus is on the leading companies and public organizations in the life sciences sector. This is the industry in which we are at home and in which we have sustainable success through the definition, implementation and introduction of forward-looking methods, strategies and solutions.
To learn more about Main5, visit https://www.main5.com/.

Media Contact
Rob Patterson
Chief Marketing Officer
Astrix
rpatterson@astrixinc.com

Robert Patterson
Astrix, LLC
+1 (732) 661-0400
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

About The Author
Written By: EIN Presswire